Joel Greenblatt Rhythm Pharmaceuticals, Inc. Transaction History
Gotham Asset Management, LLC
- $7.56 Billion
- Q2 2024
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 12,627 shares of RYTM stock, worth $676,807. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,627
Previous 11,103
13.73%
Holding current value
$676,807
Previous $481,000
7.69%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding RYTM
# of Institutions
178Shares Held
69.1MCall Options Held
467KPut Options Held
224K-
Primecap Management CO Pasadena, CA7.31MShares$392 Million0.22% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$361 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$343 Million3.49% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$326 Million3.77% of portfolio
-
Goldman Sachs Group Inc New York, NY5.29MShares$283 Million0.04% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $2.99B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...